Skip to main content
Top
Published in: Comparative Clinical Pathology 6/2017

Open Access 01-11-2017 | Original Article

Effects of repeated restraint and blood sampling with needle injection on blood cardiac troponins in rats, dogs, and cynomolgus monkeys

Authors: Keisuke Nagata, Kazutoshi Sawada, Hirofumi Minomo, Daisuke Sasaki, Katsuyuki Kazusa, Kazuhiko Takamatsu

Published in: Comparative Clinical Pathology | Issue 6/2017

Login to get access

Abstract

While cardiac troponins (cTnT and cTnI) have been used as blood biomarkers of myocardial injury such as myocardial infarction in both humans and animals, their high diagnostic sensitivity inevitably leads to decreased diagnostic specificity. For example, it is difficult to judge whether a slight increase of cardiac troponins in toxicological studies is a treatment-related response or not. Drawing an accurate conclusion requires reliable background data and definitive criteria based on that data. However, no organized efforts in setting such criteria has been reported. Here, we measured blood cTnI and cTnT concentrations in Sprague-Dawley rats, beagle dogs, and cynomolgus monkeys from repeated blood samplings using needle cylinders under restraint up until 24 h after a single oral dose of 0.5 w/v% methyl cellulose solution as a vehicle. We revealed the extent of individual differences in baseline levels and operational effects. Our results can be useful in making criteria for judgment of treatment-related changes in cardiac troponins.
Literature
go back to reference Herman EH et al (2001) The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol 48:297–304CrossRefPubMed Herman EH et al (2001) The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol 48:297–304CrossRefPubMed
go back to reference Newby LK et al (2011) Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the cardiac safety research consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration. Am Heart J 162:64–73. https://doi.org/10.1016/j.ahj.2011.04.005 CrossRefPubMed Newby LK et al (2011) Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the cardiac safety research consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration. Am Heart J 162:64–73. https://​doi.​org/​10.​1016/​j.​ahj.​2011.​04.​005 CrossRefPubMed
go back to reference Schultze AE et al (2015) Longitudinal studies of cardiac troponin I concentrations in serum from male cynomolgus monkeys: resting values and effects of oral and intravenous dosing on biologic variability. Vet Clin Pathol/Am Soc Vet Clin Pathol 44:465–471. https://doi.org/10.1111/vcp.12272 CrossRef Schultze AE et al (2015) Longitudinal studies of cardiac troponin I concentrations in serum from male cynomolgus monkeys: resting values and effects of oral and intravenous dosing on biologic variability. Vet Clin Pathol/Am Soc Vet Clin Pathol 44:465–471. https://​doi.​org/​10.​1111/​vcp.​12272 CrossRef
Metadata
Title
Effects of repeated restraint and blood sampling with needle injection on blood cardiac troponins in rats, dogs, and cynomolgus monkeys
Authors
Keisuke Nagata
Kazutoshi Sawada
Hirofumi Minomo
Daisuke Sasaki
Katsuyuki Kazusa
Kazuhiko Takamatsu
Publication date
01-11-2017
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 6/2017
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-017-2539-7

Other articles of this Issue 6/2017

Comparative Clinical Pathology 6/2017 Go to the issue